Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

United Therapeutics Corp (NASDAQ:UTHR)

117.38
BATS BZX Real-Time Price
As of 1:09pm ET
 +2.36 / +2.05%
Today’s Change
97.52
Today|||52-Week Range
164.04
-25.05%
Year-to-Date
5 Stocks with Exciting Price-to-Book Ratios
Sep 28 / Zacks.com - Paid Partner Content
3 Great Stocks You Can Buy on Sale
Sep 27 / MotleyFool.com - Paid Partner Content

Today’s Trading

Previous close115.02
Today’s open115.52
Day’s range114.60 - 117.55
Volume19,109
Average volume (3 months)568,486
Market cap$5.0B
Dividend yield--
Data as of 1:09pm ET, 09/30/2016

Growth & Valuation

Earnings growth (last year)+102.55%
Earnings growth (this year)+20.00%
Earnings growth (next 5 years)+0.70%
Revenue growth (last year)+13.76%
P/E ratio5.8
Price/Sales5.47
Price/Book3.31

Competitors

 Today’s
change
Today’s
% change
TAROTaro Pharmaceutical ...-0.92-0.81%
ENDPEndo International P...-0.54-2.58%
TSROTESARO Inc-0.44-0.44%
IONSIonis Pharmaceutical...+1.07+3.01%
Data as of 1:11pm ET, 09/30/2016

Financials

Next reporting dateOctober 25, 2016
EPS forecast (this quarter)$3.38
Annual revenue (last year)$1.5B
Annual profit (last year)$651.6M
Net profit margin44.46%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Other
Chairman &
Chief Executive Officer
Martine A. Rothblatt
President &
Chief Operating Officer
Michael Benkowitz
Corporate headquarters
Silver Spring, Maryland

Forecasts

Search for Jobs